Iqvia Holdings Inc (IQV) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Iqvia Holdings Inc   (NYSE: IQV)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Iqvia Holdings Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Iqvia Holdings Inc's ROI in the first quarter of 2026?
Iqvia Holdings Inc achieved a return on average invested assets (ROI) of 5.95 % in its first quarter of 2026, which is below Iqvia Holdings Inc's average return on investment, which stands at 7.53%.

Despite the deterioration in its net income, company has improved ROI compared to the fourth quarter of 2025.

Within the Healthcare sector 150 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 873 to 1370.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM 13.76 % 14.5 % 9.28 % 7.46 % 3.54 %
Y / Y Net Income Change TTM 3.97 % -0.87 % 37.18 % 90.02 % 363.19 %
Investment (TTM) in Millions 23,735 23,851 22,507 23,191 22,091
Return On Investment (TTM) 5.95 % 5.94 % 5.85 % 5.79 % 6.51 %
IQV's Overall Ranking # 1370 # 873 # 1092 # 1033 # 1013
Seq. Investment Change TTM 1.79 % 4.46 % 2.72 % 4.16 % 2.46 %
Seq. Net Income Change TTM 1.91 % 6 % 3.8 % -7.27 % -2.84 %
Net Income (TTM) in Millions 1,387 1,361 1,284 1,237 1,334

IQV Company Profile >> Back to IQV Roi Comparisons >> See Annual IQV Return On Investment



Return On Investment IQV's Ranking
Within: No.
Industry # 9
Sector # 151
Overall # 1370

Return On Investment Statistics
High Average Low
20.89 %
7.53 %
0.39 %
(Dec 31 2014)   (Sep 30 2017)







Financial Statements
Iqvia Holdings Inc's I. Quarter Investments $ 23,735 Millions IQV's Balance sheet
Iqvia Holdings Inc's I. Quarter Income $ 275 Millions Quarterly IQV's Income Statement
IQV's Income by Division See IQV's Income by Division


IQV Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 21,733 19,942 20,190 19,759 19,448
Y / Y Investment Growth 8.98 % -1.23 % 2.18 % 1.6 % -4.13 %
Net Income in Millions 1,361 1,373 1,358 1,091 971
Y / Y Net Income Growth -0.87 % 1.1 % 24.47 % 12.36 % 215.26 %
Annual Return On Investment 6.26 % 6.88 % 6.73 % 5.52 % 4.99 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 6.26 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IQV's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IQV's Competitors
Subscribers only: Roi for Iqvia Holdings Inc's Suppliers
Subscribers only: Return On Investment for IQV's Customers

Other Ratios
IQV's Roa IQV's Inventory Turnover Ratio IQV's Growth Rates IQV's Dividend Statistics
IQV's Profitability Ratios IQV's Asset Turnover Ratio IQV's Dividend Growth
IQV's Roe IQV's Valuation Ratios IQV's Financial Strength Ratios IQV's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI
Alnylam Pharmaceuticals Inc   16.15 %
Strata Critical Medical Inc   16.15 %
Standard Biotools Inc   15.94 %
Profound Medical Corp   15.18 %
West Pharmaceutical Services Inc   14.67 %
Embecta Corp   14.58 %
Lantheus Holdings Inc   14.24 %
Lifevantage Corp  13.20 %
Harmony Biosciences Holdings inc   13.07 %
Sbc Medical Group Holdings Incorporated  13.05 %
Johnson and Johnson  13.01 %
Progyny Inc   12.72 %
Universal Health Services Inc   12.68 %
Insulet Corporation  12.55 %
Encompass Health Corporation  12.43 %
Globus Medical Inc   12.37 %
Regeneron Pharmaceuticals Inc   12.19 %
Medinotec Inc   12.13 %
Msa Safety Inc  12.11 %
Healthcare Services Group Inc   12.09 %
Amgen Inc   12.04 %
Alpha Pro Tech Ltd   11.97 %
Kiniksa Pharmaceuticals International Plc  11.92 %
Prestige Consumer Healthcare Inc   11.89 %
Mimedx Group Inc   11.75 %
Ufp Technologies Inc   11.69 %
Ligand Pharmaceuticals Incorporated  11.46 %
Cryoport inc   11.23 %
Solventum Corporation  11.19 %
Nature s Sunshine Products inc   11.05 %

Date modified: 2026-09-26T06:58:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.